Office and commercial relocation company, Business Moves Group (BMG), has won the contract to manage relocation of the Scottish National Blood Transfusion Service (SNBTS), a division of NHS National Services Scotland (NSS) – to its new headquarters in Edinburgh.
The complex transit, which is to be executed in phases from January to May 2017, covers all operational elements of the organisation from standard office supplies to specialist medical equipment. Some of the materials that require careful relocation include sub-zero laboratory freezers, centrifuges, and incubators as well as blood manufacturing, and tissue and cell processing equipment.
SNBTS’ new HQ is located in the Heriot-Watt Research Park, Riccarton, Edinburgh. The purpose built facility will deal with the manufacturing, testing and distribution of blood, tissue and cell products for all of Scotland. Construction of the building is being undertaken by Interserve Construction Ltd.
Rachel Walton, managing director of BMG commented:
“BMG’s skill and experience with complex transits means our workforce is well prepared to relocate this sensitive cargo. In addition to this, BMG is confident that the equally important workforce which runs SNBTS will be moved efficiently in order to seamlessly continue their vital service.”
Safia Qureshi, spokesperson for SNBTS added:
“We are confident that BMG will enable a smooth transition to our new headquarters. This move will consolidate SNBTS’s processing and testing facilities in the Central belt streamlining the provision of blood, tissues and cells to the people of Scotland.”
SNBTS currently operate across Scotland, with manufacturing operations divided between different sites. SNBTS offered to outsource all logistical features of the move from planning, management and delivery of its services from existing sites: Lauriston Place, Edinburgh; Ellen’s Glen Road, Edinburgh: and Gartnavel, Glasgow to the facility. The newly built centre will consolidate the main functions of SNBTS in one central location and in doing so ensure the key priorities of SNBTS are met.
The services which SNBTS provide are highly regulated by external agencies which act on behalf of the government and each stage of the phased transition requires approval before the next can follow. BMG was selected due to its recent experience in laboratory migration, successfully delivering the recent Rowett Institute Laboratory and Queen Elizabeth Hospitals migration projects to a particularly high standard.
It is expected that office, warehouse and laboratory functions will transfer before the end of January 2017, whereas blood processing and tissue services will be transported in phased stages from January onwards.